Evidence map›Paper›PMID 32456302›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Antifungal Potential of Nanostructured Crystalline Copper and Its Oxide Forms.

Auriane Fifame Oussou-Azo, Tomoki Nakama, Masayuki Nakamura, Taiki Futagami, Mun'delanji Catherine M Vestergaard

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. A comprehensive review on potential applications of metallic nanoparticles as antifungal therapies to combat human fungal diseases.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  8. Synthesis of TiONanomaterials (Basel, Switzerland) · 2023
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Auriane Fifame Oussou-AzoUnited Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan.
Tomoki NakamaFaculty of Agriculture, Kagoshima University, 1-21-24 Korimoto, Kagoshima 890-0065, Japan.
Masayuki NakamuraUnited Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan.
Taiki FutagamiUnited Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan.
Mun'delanji Catherine M VestergaardUnited Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan.
Kagoshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copper has been used as an antimicrobial agent for over a century and is now being added to commercial fungicides. Nanomaterials have attracted much attention due to the special properties they have over their bulk form. We studied nanostructured copper (Cu-NPs), investigating the potential for improved antifungal properties derived from its special properties and studied any effect that the oxidation of copper (CuO-NPs) may have. We conducted this research against

Indexed as

antifungalcell viabilityColletotrichum gloeosporioidescopper nanoparticlescopper oxidesnanostructured copper

Identifiers

PMID32456302
PMCPMC7279545
OpenAlexW3028416564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.